Tonix Pharmaceuticals Holding (TNXP) Total Liabilities (2010 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Total Liabilities of $30.8 million for Q1 2026, up 146.71% year-over-year from $12.5 million in Q1 2025, and down 3.89% quarter-over-quarter from $32.0 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Total Liabilities (2010 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Total Liabilities history runs 17 years deep, the most recent figure standing at $30.8 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 146.71% year-over-year to $30.8 million; the TTM figure through Mar 2026 stood at $30.8 million (up 146.71% YoY), while the FY2025 annual figure was $32.0 million, up 37.24% from the prior year.
- Total Liabilities for Q1 2026 stood at $30.8 million, down from $32.0 million in the prior quarter.
- The five-year high for Total Liabilities was $48.9 million in Q4 2023, with the low at $12.5 million in Q1 2025.
- The 5-year median for Total Liabilities is $19.4 million (2025), against an average of $22.4 million.
- The sharpest annual moves came in 2023 and 2025: Total Liabilities soared 164.38% in 2023, then sank 54.14% in 2025.
- Tonix Pharmaceuticals Holding's Total Liabilities stood at $18.5 million in 2022, then jumped by 164.38% to $48.9 million in 2023, then plunged by 52.32% to $23.3 million in 2024, then surged by 37.24% to $32.0 million in 2025, then dropped by 3.89% to $30.8 million in 2026.
- Business Quant data shows TNXP's Total Liabilities at $30.8 million in Q1 2026, $32.0 million in Q4 2025, and $21.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | 31.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.81 Mn |
| Mar 31, 2026 | 30.78 Mn |
| Dec 31, 2025 | 32.02 Mn |
| Sep 30, 2025 | 21.30 Mn |
| Jun 30, 2025 | 19.36 Mn |
| Mar 31, 2025 | 12.47 Mn |
| Dec 31, 2024 | 23.33 Mn |
| Sep 30, 2024 | 20.78 Mn |
| Jun 30, 2024 | 28.20 Mn |
| Mar 31, 2024 | 27.20 Mn |
| Dec 31, 2023 | 48.93 Mn |
| Sep 30, 2023 | 18.45 Mn |
| Jun 30, 2023 | 19.27 Mn |
| Mar 31, 2023 | 13.66 Mn |
| Dec 31, 2022 | 18.51 Mn |
| Sep 30, 2022 | 13.72 Mn |
| Jun 30, 2022 | 16.38 Mn |
| Mar 31, 2022 | 15.76 Mn |
| Dec 31, 2021 | 22.18 Mn |
| Sep 30, 2021 | 12.56 Mn |